Nutritional supplements like Rutaecarpine have many health benefits and are being widely used by cancer patients and those at-genetic-risk of cancer. But, is it safe to take Rutaecarpine supplements for all types of cancer and without considering any ongoing treatments and other lifestyle conditions? A common belief but only a myth is that anything natural can only benefit me or do no harm. As one example, the use of grapefruit with certain medications is not recommended. Another example, the use of spinach with some blood thinning medications can cause adverse interactions and should be avoided. For cancer, nutrition which includes the food and natural supplements has been shown to influence outcomes. Hence a frequently asked question by cancer patients to dieticians and doctors is “What Should I eat and What Should I Avoid?”.
Taking nutritional Rutaecarpine supplements can benefit Renal Non-Clear Cell Carcinoma/Cancer patients on Bevacizumab treatment. But avoid Rutaecarpine supplements if on Ifosfamide treatment for Seminoma. Similarly, taking nutritional supplement Rutaecarpine can benefit healthy individuals who are at genetic risk of cancer due to mutation of gene MET. But avoid taking nutritional supplement Rutaecarpine when at genetic risk of cancer due to mutation of gene TERT.
The takeaway being – your individual context will influence your decision if nutritional supplement Rutaecarpine is safe or not. And also that this decision needs to be constantly revisited as conditions change. Conditions like cancer type, current ongoing treatments and supplements, age, gender, weight, height, lifestyle and any genetic mutations identified matter. So a legitimate question for you to ask for any recommendation of food and natural supplement is how it is related to your individual context.
Nutritional supplements – vitamins, herbs, minerals, probiotics, and other specialty categories are increasing. Supplements are high concentrations of active ingredients which are also found in different foods. The difference being foods contain more than one active ingredient at lower diffused concentrations. Remember that each of these ingredients has its own science and biological mechanism at molecular level – hence choose the right combination of supplements like Rutaecarpine based on individual context and conditions.
So the question is should you take the supplement Rutaecarpine? Should you take it when at genetic risk of cancer for mutation of gene TERT? Should you take it when at genetic risk of cancer for mutation of gene MET? Should you take it when diagnosed with Seminoma? Should you take it when diagnosed with Renal Non-Clear Cell Carcinoma? Should you take it when on Ifosfamide treatment? Should you continue taking Rutaecarpine supplement if you change your treatment from Ifosfamide to Bevacizumab? So a general explanation like – it is natural or it increases immunity may not be acceptable and sufficient for choosing Rutaecarpine.
Cancer remains an unsolved problem statement. The improved availability of personalized treatments and monitoring of cancer via blood and saliva have been significant factors to improve outcomes. The earlier the intervention – the better the influence on outcome. Genetic testing has the potential to assess cancer risk and susceptibility early. But besides regular monitoring in most cases there are no therapeutic intervention options available. After diagnosis with cancer such as Seminoma or Renal Non-Clear Cell Carcinoma, the treatments get personalized to tumor genomics and factors like staging of disease, age and gender. During cancer remission (after treatment cycle is complete) – monitoring is used for assessment of any relapse and accordingly decide next steps. A large majority of cancer patients and those at-risk do take nutritional supplements like Rutaecarpine.
So the question is that are all genetic mutation risks and types of cancers to be considered as one when deciding the use of Rutaecarpine? Are the biochemical pathway implications of genetic risk for cancer due to mutation of gene TERT the same as due to mutation of gene MET? Are the implications of Seminoma same as Renal Non-Clear Cell Carcinoma? Is it one and the same if you are on treatment with Ifosfamide or on Bevacizumab?
Rutaecarpine – A Nutritional Supplement
Rutaecarpine is an alkaloid usually extracted from a tree called Evodia rutaecarpa (Wu Zhu Yu), native to China and Korea. It is known to have antioxidant, antiplatelet and anti-inflammatory properties and may also enhance the metabolism of caffeine. (Kun-Ming Tian et al, Pharmacol Res., 2019; J R Sheu et al, Thromb Res., 1998; Keumhan Noh et al, Arch Pharm Res., 2011) Hence, Evodia has been widely used in Traditional Chinese Medicine for years. Following are some of the potential health benefits of Rutaecarpine:
- May be beneficial for headache, abdominal pain, vomiting, cold and reduced blood circulation (Sook-Kyoung Heo et al, J Cell Biochem., 2009)
- May help reduce cardiovascular problems (Kun-Ming Tian et al, Pharmacol Res., 2019)
- May help relieve pain and swelling
- May help decrease blood pressure (Xu-Ping Qin et al, Clin Exp Pharmacol Physiol., 2009)
- May help decrease diarrhea
The molecular pathways which are regulated by Rutaecarpine include Oxidative Stress, Epithelial to Mesenchymal Transition, MYC Signaling, Adherens junction and MAPK Signaling. These cellular pathways directly or indirectly regulate specific cancer molecular endpoints like growth, spread and death. Because of this biological regulation – for cancer nutrition, the right choice of supplements like Rutaecarpine individually or in combination is an important decision to be made. When making decisions on the use of supplement Rutaecarpine for cancer – do consider all these factors and explanations. Because just as true for cancer treatments – Rutaecarpine use cannot be a one-size-fits-all decision for all types of cancers.
Choosing Rutaecarpine Supplements for Your Cancer
The reason there is no easy way to answer the question “When should I avoid Rutaecarpine for Cancer” is because “It Depends!”. Just like the same treatment does not work for every cancer patient, based on your individual context the Rutaecarpine may be harmful or safe. Along with which cancer and associated genetics – the ongoing treatments, supplements, lifestyle habits, BMI and allergies are all factors deciding if Rutaecarpine should be avoided or not and why.
1. Will Rutaecarpine Supplements benefit Cancer Patients with Seminoma undergoing Ifosfamide treatment?
Seminoma is characterized and driven by specific genetic mutations like KIT and KRAS leading to biochemical pathway changes in Oxidative Stress, PI3K-AKT-MTOR Signaling, RAS-RAF Signaling and MAPK Signaling. A cancer treatment like Ifosfamide works through a specific pathway mechanism of action. The goal is to have a good overlap between the treatment and cancer driving pathways for a personalized approach which is effective. In such a condition any food or nutritional supplement which has a contrary effect to the treatment or reduces the overlap should be avoided. As an example, Rutaecarpine should be avoided for Seminoma along with the treatment Ifosfamide. Rutaecarpine impacts pathways/processes like Oxidative Stress which either promote drivers of the disease and/or nullify the treatment effect. Some of the factors which should be considered when choosing nutrition are type of cancer, treatments and supplements being taken currently (if any), age, gender, BMI, lifestyle and any genetic mutation information (if available).
2. Will Rutaecarpine Supplements benefit Cancer Patients with Renal Non-Clear Cell Carcinoma undergoing Bevacizumab Treatment?
Renal Non-Clear Cell Carcinoma is characterized and driven by specific genetic mutations like MUC16 and TP53 leading to biochemical pathway changes in Epithelial to Mesenchymal Transition, Oxidative Stress, Hypoxia, Small Molecule Transport and PI3K-AKT-MTOR Signaling. A cancer treatment like Bevacizumab works through specific pathway mechanisms. The goal is to have a good overlap between the treatment and cancer driving pathways for a personalized approach. In such a condition any food or nutritional supplement which has a compatible effect to the treatment or reduces the overlap should be considered. As an example, Rutaecarpine supplements should be considered for Renal Non-Clear Cell Carcinoma along with treatment Bevacizumab. Rutaecarpine supplement impacts pathways/processes like Epithelial to Mesenchymal Transition and Oxidative Stress which either obstruct drivers of the disease and/or improve Bevacizumab treatment effect.
Foods to Eat After Cancer Diagnosis!
No two cancers are the same. Go beyond the common nutrition guidelines for everyone and make personalized decisions about food and supplements with confidence.
3. Are Rutaecarpine Supplements Safe for Healthy Individuals with TERT Mutation Associated Genetic Risk?
Different companies offer panels of genes to be tested for assessing genetic risk to different cancers. These panels cover genes associated with cancers of the breast, ovary, uterus, prostate, and gastrointestinal system and others. Genetic testing of these genes may confirm a diagnosis and help guide treatment and management decisions. Identification of a disease-causing variant may also guide testing and diagnosis of at-risk relatives.
TERT is one of the genes generally available in panels for cancer risk testing. TERT mutation causes biochemical pathways/processes like MYC Signaling, MAPK Signaling, Nucleotide metabolism, Stem Cell Signaling and Hypoxia to get impacted. These pathways are direct or indirect drivers of cancer molecular endpoints. Rutaecarpine should be avoided when the genetic panel identifies mutation of TERT for Hematological Cancer. Rutaecarpine impacts pathways/processes like MYC Signaling and MAPK Signaling and creates adverse effects with TERT and related conditions.
4. Are Rutaecarpine Supplements Safe for Healthy Individuals with MET Mutation Associated Genetic Risk?
MET is one of the genes available in panels for cancer risk testing. MET mutation causes biochemical pathways/processes like Adherens junction, RAS-RAF Signaling, Stem Cell Signaling, Cytoskeletal Dynamics and Endoplasmic Reticulum Stress to get impacted. These pathways are direct or indirect drivers of cancer molecular endpoints. Consider taking Rutaecarpine supplements when the genetic panel identifies mutation in MET for Kidney Cancer. Rutaecarpine impacts pathways/processes like Adherens junction and RAS-RAF Signaling and creates a supportive effect in those with MET mutation and related conditions.
* Other Factors are also included like BMI, Treatments, Lifestyle Habits
The two most important things to remember are that cancer treatments and nutrition are never the same for everyone. Nutrition, which includes food and nutritional supplements like Rutaecarpine, is an effective tool which can be controlled by you, while facing cancer.
What food you eat and which supplements you take is a decision you make. Your decision should include consideration of the cancer gene mutations, which cancer, ongoing treatments and supplements, any allergies, lifestyle information, weight, height and habits.
The nutrition planning for cancer from addon is not based on internet searches. It automates the decision making for you based on molecular science implemented by our scientists and software engineers. Irrespective of whether you care to understand the underlying biochemical molecular pathways or not - for nutrition planning for cancer that understanding is needed.
Get started NOW with your nutrition planning by answering questions on the name of cancer, genetic mutations, ongoing treatments and supplements, any allergies, habits, lifestyle, age group and gender.
Foods to Eat After Cancer Diagnosis!
Cancer patients often have to deal with different chemotherapy side effects which affect their quality of life and look out for alternative therapies for cancer. Taking the right nutrition and supplements based on scientific considerations (avoiding guesswork and random selection) is the best natural remedy for cancer and treatment related side-effects.